Cite
Stein K, Stoehr A, Klinker H, et al. Hepatitis C therapy with grazoprevir/elbasvir and glecaprevir/pibrentasvir in patients with advanced chronic kidney disease: data from the German Hepatitis C-Registry (DHC-R). Eur J Gastroenterol Hepatol. 2022;34(1):76-83doi: 10.1097/MEG.0000000000001923.
Stein, K., Stoehr, A., Klinker, H., Teuber, G., Naumann, U., John, C., Heyne, R., Serfert, Y., Niederau, C., Zeuzem, S., Berg, T., Wiegand, J. (2022). Hepatitis C therapy with grazoprevir/elbasvir and glecaprevir/pibrentasvir in patients with advanced chronic kidney disease: data from the German Hepatitis C-Registry (DHC-R). European journal of gastroenterology & hepatology, 34(1), 76-83. https://doi.org/10.1097/MEG.0000000000001923
Stein, Kerstin, et al. "Hepatitis C therapy with grazoprevir/elbasvir and glecaprevir/pibrentasvir in patients with advanced chronic kidney disease: data from the German Hepatitis C-Registry (DHC-R)." European journal of gastroenterology & hepatology vol. 34,1 (2022): 76-83. doi: https://doi.org/10.1097/MEG.0000000000001923
Stein K, Stoehr A, Klinker H, Teuber G, Naumann U, John C, Heyne R, Serfert Y, Niederau C, Zeuzem S, Berg T, Wiegand J. Hepatitis C therapy with grazoprevir/elbasvir and glecaprevir/pibrentasvir in patients with advanced chronic kidney disease: data from the German Hepatitis C-Registry (DHC-R). Eur J Gastroenterol Hepatol. 2022 Jan 01;34(1):76-83. doi: 10.1097/MEG.0000000000001923. PMID: 32956186.
Copy
Download .nbib